Rotavirus (RVV)

The Rotavirus Vaccine (RVV) is given to infants to protect against rotavirus infections, which can cause severe diarrhea, dehydration, and vomiting. It is administered orally in multiple doses, starting at 6 weeks of age. RVV helps reduce hospitalizations and severe cases of rotavirus-related illness in young children, contributing to better child health outcomes globally. The vaccine is an important tool in preventing rotavirus gastroenteritis, particularly in regions with high disease burden.